R&D / Pipeline
HRA Pharma is currently developing a number of products for reproductive health and endocrine diseases. In addition the company takes active part in the emergence of regenerative medicine by supporting enhancement of cell-based technologies via its subsidiary Celogos.
Details of these product candidates are shown below.
